Doyle Mittie sold AVTX
June 10, 2026 · Form 4 insider transaction
Doyle Mittie sold 1,084 shares of Avalo Therapeutics, Inc. at $13.10 per share, a transaction worth $14.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,084
Price
$13.10
Total value
$14.2K
InsiderDoyle Mittie
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateJune 10, 2026
Filing dateJune 12, 2026
Shares owned after51,776
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 5,738 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.